AstraZeneca signs up to $555 million deal with US-based Algen to develop gene therapies - Reuters

Reuters | Oct. 6, 2025, 8:06 a.m. | Original
AstraZeneca signs up to $555 million deal with US-based Algen to develop gene therapies Reuters
US holiday online sales growth to slow on economic uncertainty: Adobe Analytics - Reuters US holiday sales growth to be muted this year, forecasts show - Reuters